Childhood Acute Lymphoblastic Leukemia: Clinical Trials

1 trial for Childhood Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Childhood Acute Lymphoblastic Leukemia: new trials by email Literature Review of Childhood Acute Lymphoblastic Leukemia trials Research Report on Childhood Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia
Idarubicin(IDA) - Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent
Phase 4UnknownChinese Academy of Medical Sciences202012-10-012013-11-21

Narrower conditions

Philadelphia Chromosome (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Chromosome Aberrations (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Translocation, Genetic (1)

Interventions

Idarubicin (1)

Sponsors

Chinese Academy of Medical Sciences (1)

Countries

China (1)

Top investigators

Xiaofan Zhu, MD (1)